Timber pharmaceuticals expect to complete enrollment of patients in both tmb-001 and tmb-002 studies during early months of 2021

Timber pharmaceuticals provides business update and announces second quarter 2020 financial results.timber pharmaceuticals - expect to complete enrollment of patients in both tmb-001 and tmb-002 studies during early months of 2021.timber pharmaceuticals - expect cash balance of nearly $14 million will fund trials & operations through completion of current tmb-001 & tmb-002 studies.
TMBR Ratings Summary
TMBR Quant Ranking